Identifying differences in bile acid pathways for cholesterol clearance in Alzheimer’s disease using metabolic networks of human brain regions
暂无分享,去创建一个
Cory C. Funk | James T. Yurkovich | N. Price | A. Saykin | Jingwen Yan | K. Nho | I. Thiele | R. Kaddurah-Daouk | J. Yurkovich | A. Heinken | G. Kastenmüller | M. Arnold | P. Baloni | W. Jia | W. Griffiths | Siamak Mahmoudiandehkordi | Gregory Louie | Alexandra Kueider-Paisley | Siamak MahmoudianDehkordi
[1] Arthur W. Toga,et al. Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data Across 27 Tissue Types , 2018, bioRxiv.
[2] J. Gustafsson,et al. Concentrations of bile acid precursors in cerebrospinal fluid of Alzheimer's disease patients , 2019, Free radical biology & medicine.
[3] Paul Shannon,et al. Genome-Scale Transcriptional Regulatory Network Models of Psychiatric and Neurodegenerative Disorders. , 2019, Cell systems.
[4] Anne Richelle,et al. Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0 , 2019, Nature Protocols.
[5] A. Mulak,et al. Brain-Gut-Microbiota Axis in Alzheimer’s Disease , 2019, Journal of neurogastroenterology and motility.
[6] Xianlin Han,et al. Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers , 2018, Alzheimer's & Dementia.
[7] Xianlin Han,et al. Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome , 2018, Alzheimer's & Dementia.
[8] S. DeMorrow. Bile Acids in Hepatic Encephalopathy. , 2019, Journal of clinical and experimental hepatology.
[9] Herbert Yu,et al. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure , 2018, EBioMedicine.
[10] M. Mattson,et al. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. , 2018, Cell metabolism.
[11] Pierre Orban,et al. Brain properties predict proximity to symptom onset in sporadic Alzheimer’s disease , 2018, Brain : a journal of neurology.
[12] Seth A Ament,et al. Transcriptional regulatory networks underlying gene expression changes in Huntington's disease , 2018, Molecular systems biology.
[13] Ronan M. T. Fleming,et al. When metabolism meets physiology: Harvey and Harvetta , 2018, bioRxiv.
[14] Avlant Nilsson,et al. Recon3D: A Resource Enabling A Three-Dimensional View of Gene Variation in Human Metabolism , 2018, Nature Biotechnology.
[15] Ronan M. T. Fleming,et al. Personalized modeling of the human gut microbiome reveals distinct bile acid deconjugation and biotransformation potential in healthy and IBD individuals , 2017, bioRxiv.
[16] J. Chiang. Recent advances in understanding bile acid homeostasis , 2017, F1000Research.
[17] G. Kemmler,et al. Bile acid quantification of 20 plasma metabolites identifies lithocholic acid as a putative biomarker in Alzheimer’s disease , 2017, Metabolomics.
[18] A. Kalsbeek,et al. Bile Acid Signaling Pathways from the Enterohepatic Circulation to the Central Nervous System , 2017, Front. Neurosci..
[19] C. Hölscher,et al. Metabolomic Profiling of Bile Acids in Clinical and Experimental Samples of Alzheimer’s Disease , 2017, Metabolites.
[20] W. Griffiths,et al. Cholesterolomics: An update , 2017, Analytical biochemistry.
[21] Helen Tremlett,et al. The gut microbiome in human neurological disease: A review , 2017, Annals of neurology.
[22] G. Barreto,et al. Genome-Scale Reconstruction of the Human Astrocyte Metabolic Network , 2017, Front. Aging Neurosci..
[23] J. Griffin,et al. Amino Acid Catabolism in Alzheimer's Disease Brain: Friend or Foe? , 2017, Oxidative medicine and cellular longevity.
[24] C. Kahn,et al. Loss of astrocyte cholesterol synthesis disrupts neuronal function and alters whole-body metabolism , 2017, Proceedings of the National Academy of Sciences.
[25] Fan Liao,et al. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease , 2016, Current opinion in lipidology.
[26] H. Y. Lee,et al. Novel osmotin inhibits SREBP2 via the AdipoR1/AMPK/SIRT1 pathway to improve Alzheimer's disease neuropathological deficits , 2016, Molecular Psychiatry.
[27] Bin Zhao,et al. The Gut Microbiota and Alzheimer's Disease. , 2017, Journal of Alzheimer's disease : JAD.
[28] U. Roessner,et al. 13C metabolomics reveals widespread change in carbon fate during coral bleaching , 2017, Metabolomics.
[29] Ronan M. T. Fleming,et al. Generation of genome-scale metabolic reconstructions for 773 members of the human gut microbiota , 2016, Nature Biotechnology.
[30] Matthew McMillin,et al. Effects of bile acids on neurological function and disease , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[31] Anumantha Kanthasamy,et al. Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases. , 2016, Pharmacology & therapeutics.
[32] P. Hylemon,et al. Consequences of bile salt biotransformations by intestinal bacteria , 2016, Gut microbes.
[33] M. Artyomov,et al. Leveraging existing data sets to generate new insights into Alzheimer’s disease biology in specific patient subsets , 2015, Scientific Reports.
[34] F. Gonzalez,et al. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP , 2015, Proceedings of the National Academy of Sciences.
[35] Ping Liu,et al. Profiling of serum bile acids in a healthy Chinese population using UPLC-MS/MS. , 2015, Journal of proteome research.
[36] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[37] J. Gallacher,et al. Convergent genetic and expression data implicate immunity in Alzheimer's disease , 2014, Alzheimer's & Dementia.
[38] J. Satoh,et al. RNA-Seq Data Mining: Downregulation of NeuroD6 Serves as a Possible Biomarker for Alzheimer's Disease Brains , 2014, Disease markers.
[39] Ivan G. Costa,et al. Detection of active transcription factor binding sites with the combination of DNase hypersensitivity and histone modifications , 2014, Bioinform..
[40] Matthew McMillin,et al. Bile acids permeabilize the blood brain barrier after bile duct ligation in rats via Rac1-dependent mechanisms. , 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[41] F. Rastinejad,et al. Retinoic acid actions through mammalian nuclear receptors. , 2014, Chemical reviews.
[42] Michelle K. Lupton,et al. The role of ABCA1 gene sequence variants on risk of Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.
[43] W. Hsu,et al. STAT1 Negatively Regulates Spatial Memory Formation and Mediates the Memory-Impairing Effect of Aβ , 2013, Neuropsychopharmacology.
[44] Jason Piper,et al. Wellington: a novel method for the accurate identification of digital genomic footprints from DNase-seq data , 2013, Nucleic acids research.
[45] S. Zeisel,et al. Alteration of bile acid metabolism in the rat induced by chronic ethanol consumption , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[46] J. Chiang. Bile acid metabolism and signaling. , 2013, Comprehensive Physiology.
[47] Noffisat O. Oki,et al. Alterations in metabolic pathways and networks in Alzheimer's disease , 2013, Translational Psychiatry.
[48] C. Cudalbu,et al. Ammonia toxicity to the brain: effects on creatine metabolism and transport and protective roles of creatine. , 2015, Molecular genetics and metabolism.
[49] Nathan D. Price,et al. Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE , 2012, BMC Systems Biology.
[50] Stuart Maudsley,et al. Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. , 2012, Current Alzheimer research.
[51] Richard M. Karp,et al. Faster and More Accurate Sequence Alignment with SNAP , 2011, ArXiv.
[52] G. D. Paolo,et al. Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Neuroscience.
[53] W. Pardridge. The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.
[54] Z. Redzic. Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differences , 2011, Fluids and Barriers of the CNS.
[55] Eytan Ruppin,et al. iMAT: an integrative metabolic analysis tool , 2010, Bioinform..
[56] B. Palsson,et al. Supplement to: Formulating multi-cellular models of metabolism in tissues: application to energy metabolism in the human brain , 2010 .
[57] Ines Thiele,et al. Computationally efficient flux variability analysis , 2010, BMC Bioinformatics.
[58] R. Resende,et al. Cholesterol and statins in Alzheimer's disease: Current controversies , 2010, Experimental Neurology.
[59] William J Griffiths,et al. Bile acids: analysis in biological fluids and tissues , 2010, Journal of Lipid Research.
[60] R. Martins,et al. Cholesterol metabolism and transport in the pathogenesis of Alzheimer’s disease , 2009, Journal of neurochemistry.
[61] Terrence S. Furey,et al. F-Seq: a feature density estimator for high-throughput sequence tags , 2008, Bioinform..
[62] I. Lefterov,et al. Role of LXR and ABCA1 in the pathogenesis of Alzheimer's disease - implications for a new therapeutic approach. , 2007, Current Alzheimer research.
[63] S. Hino,et al. BBF2H7, a Novel Transmembrane bZIP Transcription Factor, Is a New Type of Endoplasmic Reticulum Stress Transducer , 2006, Molecular and Cellular Biology.
[64] J. Auwerx,et al. Endocrine functions of bile acids , 2006, The EMBO journal.
[65] W. Pardridge. Transport of nutrients and hormones through the blood-brain barrier , 1981, Diabetologia.
[66] D. Russell. The enzymes, regulation, and genetics of bile acid synthesis. , 2003, Annual review of biochemistry.
[67] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[68] P. Meier,et al. Physiological characteristics of allo-cholic acid11 Part of this work has appeared in abstract form in Gastroenterol. Hepatol. 2000. 23: 131. Published, JLR Papers in Press, September 1, 2002. DOI 10.1194/jlr.M200220-JLR200 , 2003, Journal of Lipid Research.
[69] H. Takanaga,et al. Regulation of taurine transport at the blood–brain barrier by tumor necrosis factor‐α, taurine and hypertonicity , 2002, Journal of neurochemistry.
[70] B. Angelin,et al. Differences in the Regulation of the Classical and the Alternative Pathway for Bile Acid Synthesis in Human Liver , 2002, The Journal of Biological Chemistry.
[71] Joseph L Goldstein,et al. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.
[72] Q. Smith. Transport of glutamate and other amino acids at the blood-brain barrier. , 2000, The Journal of nutrition.
[73] Shun Shimohama,et al. Alteration of transcription factors NF-κB and STAT1 in Alzheimer's disease brains , 1997, Neuroscience Letters.
[74] D. Mignault,et al. Influence of dehydrocholic acid on the secretion of bile acids and biliary lipids in rats. , 1990, Digestion.
[75] R. Spector. Fatty Acid Transport Through the Blood‐Brain Barrier , 1988, Journal of neurochemistry.
[76] W. Pardridge,et al. Palmitate and Cholesterol Transport Through the Blood‐Brain Barrier , 1980, Journal of neurochemistry.